<div class="grid-row grid-col-12 tablet:grid-col-9 main-layout with--content with--sidebar-first without--sidebar-second content-inner-regions" id="main" role="main">
<div class="grid-col-12 block block-layout-builder block-field-blocknodegeneric-lbtitle" id="node-title">
<span class="visually-hidden">Title</span>
<h1 class="block-content">
          
      Opioid Treatment Program Information for Providers
  

      </h1>
</div>
<div class="desktop:grid-col-10 tablet:grid-col-12 block block-layout-builder block-inline-blocklego-text">
<span aria-hidden="true" class="visually-hidden">Body</span>
<div class="block-content">
<div class="clearfix text-formatted field field--name-field-cpnt-body field--type-text-long field--label-hidden field__item"><h2>Division of Pharmacologic Therapies</h2>
<p>SAMHSA’s Division of Pharmacologic Therapies (DPT) works to oversee and facilitate treatment for substance use disorders. DPT, part of SAMHSA’s <a href="https://www.samhsa.gov/about/offices-centers/csat">Center for Substance Abuse Treatment (CSAT)</a>, manages the day-to-day oversight activities necessary to implement federal regulations on the use of substance use disorder medications such as <a href="https://www.samhsa.gov/substance-use/treatment/options/methadone">methadone</a> and <a href="https://www.samhsa.gov/substance-use/treatment/options/buprenorphine">buprenorphine</a> for the treatment of opioid use disorder (OUD). DPT supports the certification and accreditation of more than 1,900 opioid treatment programs (OTPs) that collectively treat more than 600,000 patients each year.</p>
<p><strong>Contact DPT</strong></p>
<p><a href="tel:240-276-2700">240-276-2700</a><br/>
<a href="mailto:DPT@samhsa.hhs.gov">DPT@samhsa.hhs.gov</a></p>
</div>
</div>
</div>
<div class="desktop:grid-col-10 tablet:grid-col-12 samhsa-collection--container">
<div class="samhsa-collection">
<div class="overide-header__card_styles">
<h2>Find Information</h2>
</div>
<ul class="usa-collection" role="list">
<div class="field field--name-field-cpnt-collection-ref-rev field--type-entity-reference-revisions field--label-hidden field__items">
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/become-otp" title="Become an Opioid Treatment Program (OTP)">
                      Become an Opioid Treatment Program (OTP)
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>To provide services for opioid use disorder patients, OTPs must successfully complete the certification and accreditation process and meet other requirements outlined in 42 CFR 8.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/sota" title="State Opioid Treatment Authorities">
                      State Opioid Treatment Authorities
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>A listing of State Opioid Treatment Authorities (SOTA) by state in alphabetical order.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/42-cfr-part-8" title="42 CFR Part 8 Final Rule">
                      42 CFR Part 8 Final Rule
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>Part 8 of Title 42 of the Code of Federal Regulations (CFR) includes the regulations that guide opioid treatment programs (OTPs); these went into effect in 2001. HHS, through the SAMHSA, revised these regulations and released the final rule in February 2024.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/exception-request" title="Submit an Opioid Treatment Exception Request">
                      Submit an Opioid Treatment Exception Request
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>Any deviation from the opioid treatment standards in 42 CFR 8 requires the submission and approval of the Form SMA-168 exception request.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/methadone-guidance" title="Take-Home Extension Guidance">
                      Take-Home Extension Guidance
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>The duration of this exemption shall be for the period of one year from the end of the COVID-19 Public Health Emergency, or until such time that final rules revising 42 C.F.R. part 8 are published by the U.S. Department of Health and Human Services, whichever occurs sooner.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/program-changes" title="Notify SAMHSA of Program Changes">
                      Notify SAMHSA of Program Changes
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>Per federal regulations opioid treatment programs (OTPs) must notify SAMHSA of changes to their existing program by logging into the SAMHSA OTP Extranet and submitting the online Form SMA-162: Application for Certification to Use Opioid Drugs in a Treatment Program.</p>
</div>
</div>
</div>
</li>
</div>
<div class="field__item"> <li class="usa-collection__item">
<div class="usa-collection__text">
<h3 class="usa-collection__heading">
<a class="usa-link" href="/substance-use/treatment/opioid-treatment-program/accreditation-bodies" title="Approved Accreditation Bodies">
                      Approved Accreditation Bodies
                  </a>
</h3>
<div class="usa-collection__body">
<div class="usa-collection__description">
<p>SAMHSA-approved accrediting bodies work to ensure that OTPs meet specific, nationally accepted standards for providing medications for substance use disorders.</p>
</div>
</div>
</div>
</li>
</div>
</div>
</ul>
</div>
</div>
<div class="desktop:grid-col-10 tablet:grid-col-12 quick-link-block">
<div class="overide-header__card_styles">
<div class="clearfix text-formatted field field--name-field-cpnt-header field--type-text-long field--label-hidden field__item"><h2>Related Pages</h2>
</div>
</div>
<div class="quick-links">
<div class="quick-link-item">
<div class="field field--name-field-cpnt-text-link field--type-link field--label-hidden field__items">
<div class="field__item"><a href="/substance-use/treatment/opioid-treatment-program/become-otp/compliance-officers">Opioid Treatment Program (OTP) Compliance Officers</a></div>
<div class="field__item"><a href="/substance-use/treatment/statutes-regulations-guidelines">Federal Statutes, Regulations, and Guidelines</a></div>
<div class="field__item"><a href="/substance-use/treatment/options/medications">Provider Information on Treatment Options</a></div>
<div class="field__item"><a href="/substance-use/treatment/statutes-regulations-guidelines/mate-act">Training Requirements (MATE Act) Resources</a></div>
<div class="field__item"><a href="/substance-use/treatment/resources">Practitioner Training Materials and Resources</a></div>
<div class="field__item"><a href="/sites/default/files/quick-start-guide.pdf">Buprenorphine Quick Start Guide (PDF | 1.4 KB)</a></div>
<div class="field__item"><a href="/sites/default/files/quick-start-pocket.pdf">Buprenorphine Pocket Guide (PDF | 200 KB)</a></div>
<div class="field__item"><a href="https://www.federalregister.gov/documents/2021/04/28/2021-08961/practice-guidelines-for-the-administration-of-buprenorphine-for-treating-opioid-use-disorder">Federal Register: Buprenorphine Guidelines for Prescribing Practitioners</a></div>
</div>
</div>
</div>
</div><div class="grid-col-12 block block-layout-builder block-field-blocknodegeneric-lbfield-last-updated" id="last-updated">
<span aria-hidden="true" class="visually-hidden">Last Updated</span>
<div class="block-content">
<div class="last-updated">
    Last Updated: 04/02/2025
  </div>
</div>
</div>
</div>